Arkolith/Insider Trading/PTHS/Form 4

Davis Todd C

DirectorPelthos Therapeutics Inc. (PTHS) · full profile →Form 4 · filed Jun 15, 2026
Net Buying
Open-Market Buys
$1000K
Open-Market Sells
$0
Net Open-Market Flow
$1000K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 11, 2026Buy(P)35K$27.80$986K75K
Jun 11, 2026Buy(P)503$28.73$14K76K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001919246-26-000088) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML